ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,523Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 1290

$517K Total Retail Price of All Prescriptions

Rank: 185 out of 1290

426 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

23% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 6,455 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 444 296 1 1
LISINOPRIL 332 239 2 5
AMLODIPINE BESYLATE 314 257 3 3
HYDROCODONE-ACETAMINOPHEN 304 164 S3 4 6
LEVOTHYROXINE SODIUM 276 196 5 4
OMEPRAZOLE 237 130 6 2
METOPROLOL TARTRATE 197 132 7 7
METFORMIN HCL 190 129 8 10
ATENOLOL 174 122 9 18
FUROSEMIDE 172 162 10 9
GABAPENTIN 166 117 11 8
ATORVASTATIN CALCIUM 146 116 12 23
SERTRALINE HCL 145 82 13 36
WARFARIN SODIUM 138 98 14 22
LOSARTAN POTASSIUM 126 125 15 19
LOVASTATIN 123 87 16 45
METOPROLOL SUCCINATE 120 66 17 14
ZOLPIDEM TARTRATE 115 77 18 15
BACLOFEN 114 42 19 122
POTASSIUM CHLORIDE 109 100 20 35
MELOXICAM 95 49 21 31
FENTANYL 92 53 S2 22 89
GLYBURIDE 91 67 R 23 87
GLIMEPIRIDE 89 77 24 57
TRAMADOL HCL 86 46 25 25
BENAZEPRIL HCL 85 62 26 140
CLONIDINE HCL 83 53 27 66
CARVEDILOL 81 63 28 12
HYDROCHLOROTHIAZIDE 81 66 28 20
DONEPEZIL HCL 80 80 30 13
CRESTOR 79 54 31 17
NEXIUM 77 34 32 34
MORPHINE SULFATE ER 74 21 S2 33 55
GLYBURIDE-METFORMIN HCL 73 52 R 34 147
PROAIR HFA 71 21 35 73
OXYCODONE HCL-ACETAMINOPHEN 69 21 S2 36 52
QUETIAPINE FUMARATE 69 48 36 80
ALPRAZOLAM 66 47 38 47
DIGOXIN 66 65 38 51
TRAZODONE HCL 63 28 40 44
LANTUS SOLOSTAR 63 37 40 88
CITALOPRAM HBR 61 52 42 29
PRAVASTATIN SODIUM 59 49 43 42
LORAZEPAM 59 39 43 132
RANITIDINE HCL 58 38 45 49
TAMSULOSIN HCL 58 50 45 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 44 45 92
CYCLOBENZAPRINE HCL 58 17 R 45 105
TRIAMCINOLONE ACETONIDE 54 28 49 102
MIRTAZAPINE 50 45 50 93
ALENDRONATE SODIUM 50 38 50 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.